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1. Introduction  
Several lymphotropic viruses manipulate host innate immune response to escape immune 
recognition and improve viral replication and spreading. From this point of view HIV 
(Human Immunodeficiency Virus-1) represents a paradigmatic example (for review see 
Peterlin & Trono, 2003). HIV-1 encodes the classical structural and enzymatic factors of all 
retroviruses codified from the gag (group-specific antigen), pol (polymerase) and env 
(envelope) genes. In addition it codes two regulatory proteins that are essential for viral 
replication (i.e., the transcriptional transactivator Tat and the regulator of virion gene 
expression Rev) and four accessory proteins (i.e., the ill-named ‘negative effector’ Nef, the 
viral infectivity factor Vif, the viral protein r Vpr and the viral protein u Vpu). With time has 
become increasingly clear that the so-called accessory proteins carry out several critical 
functions for both viral replication and pathogenesis (Malim & Emerman, 2008). In 
particular, the Nef protein was demonstrated to be an important virulence factor of primate 
lentiviruses. In fact Nef-defective HIV leads to an attenuated clinical phenotype with 
reduced viral loads in mouse models, monkeys, and in human disease (Daniel et al., 1992; 
Deacon et al., 1995; Gulizia et al., 1997; Kestler et al., 1991; Kirchhoff et al., 1995) and nef 
transgenic mice develop an AIDS-like disease (Hanna et al., 1998) confirming that this viral 
protein is a major determinant of pathogenicity.  
Studies on structure and mechanism of action of the protein highlighted its multifunctional 
properties at cellular and molecular level. The open reading frame encoding Nef is located 3′ 
of the env gene, overlaps the untranslated sequences of the 3′ viral long terminal repeat and 
is translated from multiply spliced transcripts. Nef is expressed early and most abundantly 
during the infection cycle together with Tat and Rev and evidences have been reported of 
possible expression also before integration of the proviral genome (Wu & Marsh, 2001). It 
acts as a molecular adaptor inside the cell inducing genetically distinguishable, yet highly 
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conserved, effects via specific protein-protein interaction motifs (Arold & Baur, 2001; Doms 
& Trono, 2000; Geyer et al., 2001, Foster et al., 2011). In general, Nefs from all primate 
lentiviruses (i.e. HIV-1, HIV-2, and SIV) share multiple activities in vitro, but differences 
between the ability of human and simian immunodeficiency viruses to induce Nef-mediated 
internalization of the CD3 component of the T-cell receptor complex have been observed 
and have been correlated with the greater pathogenicity of HIV and the reduction of T-cell 
activation in simian immunodeficiency virus (SIV) (Schindler et al., 2006). It has been also 
observed that HIV-1 Nef treatment of uninfected cells in culture causes internalization of the 
protein in some cell types and/or activates specific intracellular signalling pathways. 
Interestingly, Nef has been found inside uninfected B cells of lymphoid follicles from 
infected individuals (Qiao et al., 2006) and recently it has been provided experimental 
evidencies that it can be transferred to uninfected cells from the infected ones via cellular 
protrusions and/or exosomes (Lenassi et al., 2010; Muratori et al., 2009; Xu et al., 2009) 
opening a new road to deepen our insight on the roles of this multifunctional protein. This 
review will focus on those recent observations trying to provide a unifying reading. 
2. Nef: A multifunctional viral adaptor 
Nef is a protein of about 200 aminoacids and the different alleles may vary slightly in length. 
Sequence analysis has identified a number of conserved motifs that are responsible for 
protein–protein interactions and for specific biological functions. The protein is co-
translationally modified by N-terminal myristoylation and is phosphorylated on specific 
aminoacid residues. Its membrane binding is critical for Nef function on cell signalling and 
membrane trafficking and requires both the covalently attached myristic acid moiety and a 
cluster of N-terminal basic residues (Bentham et al., 2006; Gerlach et al., 2010; Szilluweit et 
al., 2009). Myristoylation appears only a weak membrane-targeting signal, but the N-
terminal basic residues, especially the arginine-rich cluster (R17 to R22), are needed for the 
stable association of the viral protein with cellular membranes. Nef appears to be a 
cytoplasmic protein partially associated with cell membrane and often accumulated in 
perinuclear regions. Cellular-fractionation assays from transient transfection experiments 
showed that less than 60% of the protein is localized at membranes, while the remaining 
portion was found to be cytosolic (Kaminchik et al., 1994). Structurally the 24-29 kDa HIV-1 
Nef protein adopts a two-domain structure encompassing a flexible membrane anchor 
domain (residues 2-61 in NefSF2) and a folded core domain (residues 62-210). The core 
domain, again, contains a C-terminal flexible loop of 33 residues (152-184) that is thought to 
mediate trafficking interactions (Geyer et al., 2001). Arold and Baur speculated that after 
translation the protein adopts a close conformation where the myristoyl moiety interacts 
with a hydrophobic region on the core domain, which could explain why the majority of the 
protein is localized in the cytosol and not attached to membranes (Arold & Baur, 2001). 
Biochemical indication for myristoylation-dependent conformational changes in HIV-1 Nef 
has been obtained (Breuer et al., 2006; Dennis et al., 2005). Indeed, Nef is readily soluble in 
aqueous solution, suggesting the shielding of the lipid moiety within the protein. Protein 
structures of Nef have been determined for the core domain by NMR spectroscopy and X-
ray crystallography (Arold et al., 1997; Grzesiek et al., 1997; Lee et al., 1996) and for the 
flexible anchor domain by NMR (Geyer et al., 1999), but not yet for the full-length protein 
due to the low stability and solubility and the high degree of intrinsic flexibility. The protein 
mediates a multitude of functions, increasing the production and infectivity of viral particles 
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and inducing alteration of specific cellular signalling and trafficking pathways. It has been 
also demonstrated that the protein is able to induce the transient translocation to the cell 
membrane of the Polycomb Group protein Eed, a nuclear transcriptional repressor, leading 
to a potent stimulation of Tat-dependent HIV transcription (Witte et al., 2004). The 
cytoplasmic translocation of Eed seems to result in the removal of a block on Tat-mediated 
HIV transcription essential to promote viral transcription at low concentrations of the 
transactivator protein found at the very early phase of the infection or reactivation from 
latency. It has been proposed that Nef adopts different structural conformations inside the 
cell that allows different localizations and interaction with different partners, realizing the 
so called ”Nef interaction cycle” (Arold & Baur, 2001). In particular, Nef, after translation, 
could adopt the closed conformation in which its binding sites are mainly hidden (closed 
conformation). Contact with the cell membrane could then trigger a conformational change 
via the interaction of the negative charges of the membrane lipid heads with the positive 
charges in the N-terminus of Nef, thus relieving the interaction between the N-terminus and 
the core. This conformational change could also expose several motifs capable of binding 
signalling molecules (signalling conformation), many of which are present in lipid rafts. The 
association of Nef molecules with the membrane might persist for only a short period of 
time because of the exposure of the core loop, which would then bind molecules of the 
cellular endocytotic machinery mediating internalization of Nef together with specific 
interaction partners. 
The best characterized Nef functions are: (a) acceleration of endocytosis and lysosomal 
degradation of CD4, thereby avoiding both super-infection of infected cells and the 
interaction of budding virions with CD4 of the infected cells; (b) down-regulation of HLA-A 
and -B MHC-I molecules thereby protecting infected cells from recognition and lysis by 
cytotoxic T lymphocytes (CTL); (c) induction of a pre-activation state in CD4+ T cells 
favouring viral gene expression (Simmons et al., 2001); (d) regulation of apoptosis, 
promoting apoptosis in bystander uninfected cells meanwhile protecting the infected cells 
by apoptotic stimuli through more than one mechanism (Das & Jameel, 2005). Nef perturbs 
the trafficking of many different plasma membrane-associated proteins but how Nef traffics 
within the endosomal system to reach the perinuclear endosomal region where it is 
concentrated at steady state is not yet understood (Burtey et al., 2007; Roeth & Collins, 2006). 
The list of cellular proteins whose transport is affected has continued to grow over the past 
several years. To date it has been reported to decrease the cell surface expression of MHC-I, 
MHC-II, CD4, CD28, transferrin and mannose receptors, CD80, CD86, CD8, and CCR5 and 
to increase the expression of TNF, LIGHT, DC-SIGN, and the invariant chain (Anderson et 
al., 1993; Chaudhry et al., 2005; Lama & Ware, 2000; Madrid et al., 2005; Schindler et al., 
2003; Schwartz et al., 1996; Sol-Foulon et al., 2002; Stove et al., 2005; Stumptner-Cuvelette et 
al., 2001). The acceleration of endocytosis and lysosomal degradation of the transmembrane 
glycoprotein CD4 was one of the first discovered actions. To recruit CD4 into the 
endocytotic pathway, Nef acts as an adaptor between CD4 and components of the clathrin 
coated pits. In T cells this involves disruption of the CD4-Lck tyrosine kinase complex by 
Nef and its interaction with adaptor protein (AP) complexes and the regulatory subunit of 
the vacuolar proton pump v-ATPase. Nef binds also to the beta subunit of COPI coatomers 
(-COP) to direct CD4 to a degradation pathway. Surprisingly, Nef uses different domains 
and mechanism to downregulate MHC-I molecules (Blagoveshchenskaya et al., 2002; Doms 
& Trono, 2000). Regarding the Nef ability to induce a state of pre-activation in T cells several 
publications have reported its direct interaction with T Cell Receptor (TCR)  chain, 
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glycolipid enriched membrane microdomains (i.e., GEMs also called lipid “rafts”) and 
proteins of the submembrane TCR environment including the adaptor proteins Vav and 
LAT, and the kinases Lck, PAK and PKC (Renkema & Saksela, 2000). Mutational analysis 
suggests that most of the signaling molecules that bind to Nef interact with its core domain, 
often via the Pro-rich sequence that binds the SH3 domain of Src kinases. Nef displays high 
(i.e. nanomolar) affinity for the SH3 domain of Hck and Lyn, and rather modest (i.e. 
micromolar) affinity for those of Lck, Fyn and Src. In vivo, the individual tissue distribution 
of Src kinases become relevant because Hck is restricted to macrophages, therefore in T cells 
Nef might interact with lower-affinity targets such as Fyn or Lck. As far as regulation of 
apoptosis concerns, it appears that Nef causes bystander cell apoptosis in uninfected cells 
through its induction of FasL expression on the infected CD4+ T cell (Xu et al., 1999; Xu et 
al., 1997). Conversely, it inhibits apoptosis in virally infected host T cells both through its 
concomitant suppressive effects on ASK1, a key intermediate in the Fas and TNF death 
signaling cascade, and via Akt-indipendent phosphorylation of Bad (Geleziunas et al., 1996; 
Geleziunas et al., 2001; Wolf et al., 2001). In addition it has been described to inhibit p53-
mediated apoptosis binding the tumor suppressor (Greenway et al., 2002).  
As a consequence of Nef ability to bind multiple targets it is plausible that depending on 
Nef subcellular localization and the availability of particular subset of targets (for example 
Hck versus Lck tyrosine kinase), certain Nef effects dominate over others in a time- and cell 
type-dependent manner thus differing in infected monocyte/macrophages versus T 
lymphocytes, DC, astrocytes or microglial cells (see Quaranta et al., 2009 for the different 
regulatory effects of Nef in immune cells). In macrophages, that are important target of HIV 
infection and reservoir of the virus, Nef expression induces the release of a set of paracrine 
factors including a marked increase of CCL2/MIP-1 and CCL4/MIP-1 chemokines. These 
factors are able to recruit T cells and make them susceptible to HIV replication (Swingler et 
al., 2003; Swingler et al., 1999). In particular, Nef expression in macrophages induces also the 
production of the soluble forms of the intercellular adhesion molecule ICAM-1 (sICAM) and 
of the coactivation molecule CD23 (sCD23). sICAM and sCD23 act on B cells that cooperate 
with macrophages in inducing T cell recruitment and their permissivity to productive 
infection in vitro. The effects of Nef expression in macrophages mimics those of CD40 
Ligand (CD40L) in activating the CD40 signalling cascades suggesting that Nef intersects a 
macrophages pathway that is regulated by the CD40 receptor and requires nuclear factor 
kappa B (NF-B) activation (Swingler et al., 2003; Swingler et al., 1999). 
3. Effects induced by extracellular Nef in uninfected cells 
Evidences that Nef produced by recombinant DNA technology can induce cell signalling 
effects when added to cell cultures has been provided (Alessandrini et al., 2000; Brigino et 
al., 1997; Fujii et al., 1996c; Fujinaga et al., 1995; Huang et al., 2004; James et al., 2004; 
Lehmann et al., 2006; Okada et al., 1998; Okada et al., 1997; Qiao et al., 2006; Quaranta et al., 
1999; Quaranta et al., 2003; Tobiume et al., 2002; Varin et al., 2003). Different Nef alleles have 
been expressed in E. coli and both myristoylated (myr+) or not myristoylated (myr-) proteins 
have been produced (Breuer et al., 2006; Dennis et al., 2005). Myr+ Nef was obtained via co-
trasformation of E. coli with expression vectors coding the viral protein and the human N-
myristoyl-transferase and supplementing the culture medium with myristic acid. Purified 
myr+ and myr- wild type (wt) Nef proteins showed different oligomerisation properties in 
vitro. Indeed, myristoylated Nef prevails in a monomeric state in solution whereas the 
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nonlipidated protein forms dimers, trimers, or even oligomers of greater magnitude. When 
cell signalling effects induced by myr+ and myr- wtNef were compared in cultures of 
human monocyte-derived macrophages (MDMs), myr+ wt Nef was found to be much more 
active than the myr- protein (Mangino et al., 2007; Olivetta et al., 2003). Table 1 briefly 
summarizes the effects induced by cell treatment with Nef. In particular, negative effects on 
CD4+ T cell survival has been described (Fujii et al., 1996a; b; Fujii et al., 1996c), e.g. Nef 
treatment of CD4+ T lymphocytes in culture induced apoptosis via the interaction with the 
CXCR4 receptor (Huang et al., 2004; James et al., 2004). On immature dendritic cells (iDCs) 
exogenous Nef enhances CXCR4 expression and up-regulates MHC-II molecules, possibly 
favouring their migration and nonspecific CD4+ T cell activation (Quaranta et al., 2002). 
Exogenous Nef enters iDCs, promoting their functional and morphological differentiation. 
Specifically, Nef promotes interleukin (IL)-12 release, which closely fits with nuclear factor 
NF-B activation, and targets Vav promoting its tyrosine phosphorylation associated with 
its nucleus-to-cytoplasm redistribution. Nef induces also the rearrangement of actin 
microfilaments, leading to uropod and ruffle formation and increases the capacity of DCs to 
form clusters with allogeneic CD4+ T cells, improving immunological synapse formation 
(Quaranta et al., 2003). In addition to iDCs, Nef is internalized by primary human MDMs 
and IgD+ B cells in culture (Alessandrini et al., 2000; Qiao et al., 2006). Myr+ Nef treatment 
of primary human IgD+ B cells induced to differentiate in culture by the addition of CD40L, 
IL-4 and IL-10 inhibits switching to IgG, IgA, and IgE by inducing the negative regulators I-
B- and SOCS proteins, which block CD40L and cytokine signalling rendering Nef-
containing B cell less responsive to CD4+ T cell help (Qiao et al., 2006). Nef treatment of 
primary human MDMs down-regulated CD4 surface expression, thus reproducing an effect 
widely observed in cells endogenously expressing the viral protein. In addition, myr+ Nef 
treatment of MDMs induces the rapid (15-30’) activation of IKK/NF-B, MAPKs (i.e., 
ERK1/2, JNK and p38) and IRF-3, the main transcriptional regulator of the IFN gene 
expression, thereafter regulating the expression of many cellular transcripts (Federico et al., 
2001; Mangino et al., 2007; Olivetta et al., 2003; Percario et al., 2003). The prompt 
transcriptional reprogramming leads in 2 hours to the synthesis and release of a set of 
proinflammatory cytokines/chemokines, including TNF, IL-1, IL-6, CCL2/MIP-1 and 
CCL4/MIP-1, and of IFN that, in turn, immediately activate the signal transducers and 
activators of transcription STAT1, -2 and -3 in autocrine and paracrine manner. A transient 
STAT1, -2 and -3 tyrosine phosporylation was also observed early after (i.e. 8-16 hrs later) in 
vitro infection of 7-day old human MDMs with nef-expressing Δenv, but not Δnef/Δenv, HIV-
1 pseutotypes suggesting that intracellular signalling induced in Nef-treated MDMs might 
also be activated via Nef intracellular expression soon after MDMs infection with HIV-1 or 
viral reactivation from latency. In an attempt to identify the Nef structural motifs required 
for the activation of those signaling pathways, MDMs were treated with different myr+ 
recNefSF2 proteins lacking specific conserved aminoacid residues (Mangino et al., 2007). In 
particular, the viral protein was modified in the consensus sequence required for 
myristoylation (mutant G2→A), in the polyproline-rich region (mutant 
P76XXP79XR81→AXXAXA), in the domain required for the interaction with CD4 (mutant 
C59AWL62→AAAA) or with elements of the endocytic machinery, such as the V1H subunit 
of the vacuolar-membrane ATPase (mutant E178D179→AA) or the adaptor protein complex 
(mutant L168L169→AA) Finally a Nef protein with a deletion of the first 44 amino acids (ΔN-
term) was also used. Overall the experimental results indicated that myristoylation of the 
protein was required for the activation of the signaling cascades, because G2→A and ΔN-
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term Nef were the only two Nef mutants unable to induce signalling. These data were in 
agreement with lack of induction of STAT1, STAT2 and STAT3 tyrosine phosphorylation in 
MDMs 8 to 16 h after infection with VSV-G Δenv HIV-1 pseudotypes expressing the G2→A 
Nef mutant (Mangino et al., 2007; Percario et al., 2003). As previously mentioned 
myristoylation of Nef is a weak membrane-targeting signal and N-terminal basic residues, 
especially an arginine-rich cluster (R17 to R22), are needed for the stable association of the 
viral protein with cellular membranes. Presently, it is not possible to exclude the hypothesis 
that also these residues are important together with myristoylation for the activation of  
NF-B and IRF-3 in MDMs.  
Regarding the production of IFN we propose that Nef, abundantly expressed early after 
HIV infection together with Tat and Rev, induces IFN at a very early stage of viral infection 
or soon after reactivation of viral gene expression in latently infected cells, before the 
appearance of other viral proteins that can inhibit type I IFN production or mechanisms of 
action to allow the viral release from infected cells. In fact, even if type I IFNs inhibit the 
release of retroviral particles and their infectivity in cells chronically infected by the simplest 
retroviruses without inducing relevant reduction of viral proteins synthesis (Peng et al., 
2006; Pitha-Rowe & Pitha, 2007), the lentivirus HIV has evolved specific strategies to inhibit 
IFN-mediated antiretroviral effects at least via Vif and Vpu accessory protein functions. 
Both these viral proteins are produced later than the early HIV regulatory protein Nef and 
inhibit the function of APOBEC3 and tetherin, two cellular antiretroviral proteins 
specifically increased by type I IFN via positive transcriptional regulation (Malim & 
Emerman, 2008). In addition a recent analysis of antiviral defences in CD4+ cells during 
HIV-1 infection indicates that viral expression can also direct a global disruption of innate 
immune signalling through suppression of IRF-3 (Doehle et al., 2009). In particular, a 
marked depletion of IRF-3, but not IRF-7, was observed in HIV-1-infected cells which 
supported robust viral replication. Indeed, IRF-3 depletion was dependent on a productive 
HIV-1 replication cycle and caused the specific disruption of Toll-like and RIG-I-like 
receptors innate immune signalling. In agreement with these in vitro results, IRF-3 levels 
were found reduced in vivo within CD4+ T cells from patients with acute HIV-1 infection, 
but not from long-term non-progressors (Doehle et al., 2009). A decrease of IRF-3 expression 
after HIV-1 infection was observed also in THP-1 cells, a human monocyte/macrophage-like 
cell line, as HIV-1 infection progressed over a 48-h period. The ability of Nef to induce 
transient IFNβ production in HIV-1 infected cells in vivo needs to be investigated. Nef might 
induce IFNβ production in cells neighbouring the infected ones if the protein is secreted or 
released after cell lysis or when transferred via cell-to-cell contact to uninfected cells 
(Peterlin, 2006). This cytokine could exert its effects on bystander cells, such as the 
plasmacytoid dendritic cells, priming them to IFN production. Other HIV products (i.e., 
gp120) induce the production of type I IFNs in MDMs, as well as in PBMCs (Ankel et al., 
1994; Capobianchi et al., 1993; Capobianchi et al., 1992; Gessani et al., 1994). Induction of 
both IFN and - as a consequence of in vitro infection of MDMs cultures has been reported 
(Gessani et al., 1994; Szebeni et al., 1991) and a rapid and transient elevations in IFN has 
been observed during the cytokine storms that accompany the increase in plasma viremia in 
acute HIV-1 infection (Stacey et al., 2009). It is interesting to note that in early 1980’s one of 
the first clear-cut HIV isolate was obtained using cultured T lymphocytes, derived from a 
lymphonode biopsy specimen of a patient with lymphadenopathy, with the help of IL-2 and 
anti-IFN serum (Barre-Sinoussi et al., 1983). 
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Ref. recNef 
Alleles 
Cell type Induced Effects 
Alessandrini  
et al., 2000 
NL4-3 primary hu MDMs - CD4 downmodulation 
- Inhibition of M- and Dual-tropic 
strains replication  
Brigino et al., 1997 LAV  PBMC 
H9 
U937 
- IL-10 induction in a 
calcium/calmodulin dependent 
manner 
Creery et al., 2002  PBMC 
primary hu monocytes 
- CD14 upregulation 
Federico et al., 2001 
Mangino et al., 2007 
Olivetta et al., 2003 
Percario et al., 2003 
 
NL4-3 
BH10 
SF2 
primary hu MDMs -- Activation of NF-kB, MAPKs and 
IRF-3 signalling pathways 
- Synthesis of pro-inflammatory cyto- 
and chemokines including CCL2/MIP-
1, CCL4/MIP-1β, TNF, IL-1, IL-6 
and IFN that induce STAT1, STAT2 
and STAT3 phosphorylation in autocrine 
and paracrine manner 
- Induction of IRF-1 
Fujii et al.,  
1996 a,b,c 
 
NL4-3 CD4+ T lymphocytes - Cytotoxic effects on T cells 
- Inhibition of proliferaton 
Fujinaga et al., 1995  MOLT-20-2 - HIV reactivation from latency 
Huang et al., 2004 NL4-3 PBMC 
Jurkat 
- Apoptosis induction through Nef-
CXCR4 interaction 
James et al., 2004 NL4-3 Jurkat 
H9 
- Apoptosis induction 
Okada et al., 1997 
Okada et al., 1998 
ELI 
III B 
JA-4, Balb3T3 
EL-4, WEHI 
- Fas-independent apoptosis induction 
Qiao et al., 2006 BaL primary B cells - Suppression of CD40-dependent Ig 
class switching 
Quaranta et al., 1999 ELI hu monocyte 
/macrophages 
IL-15 synthesis induction 
Quaranta et al., 2002 
Quaranta et al., 2003 
ELI primary hu Dendritic Cells - DC maturation 
- Cytoskeleton rearrangements 
through Vav/Rac-1 dependent 
signaling 
Tobiume et al., 2002   - HIV activation from latency through 
Ras/MAPKs signaling 
Varin et al.,2003  SIVmac 
SF2 
BH10 
U937 
U1 
 
- Stimulation of HIV transcription 
through NF-κB, AP-1 and c-JNK 
signaling 
Table 1. Effects induced by cell treatment with recombinant Nef 
Regarding the response of astrocytes to extracellular Nef, treatment of uninfected cells (i.e. 
human glioblastoma/astrocytoma cell line U373MG) with the purified viral proteins Nef 
induces the synthesis of C3 (Speth et al., 2002). A significant difference in the C3 synthesis in 
Nef-treated cells was visible after 3 days and maximal effect was reached after 9 days. 
Besides Nef, also whole HIV virions and gp41 were biologically active in upregulating C3, 
whereas Tat, gp120, and gp160 were not (Speth et al., 2002). The complement system is of 
special importance in the brain because the elements of adaptive immunity have only 
www.intechopen.com
 
HIV-Host Interactions 
 
68
limited access due to the blood-brain barrier. The complement factor C3 is a central protein 
of the cascade, and its fragments (C3b, iC3b, C3d, and C3a) affect many cellular processes in 
the brain, such as activation of signalling pathways and modulation of cytokine synthesis. In 
general, all complement proteins can be synthesized by various brain cells, including 
astrocytes, neurons, microglia, and oligodendrocytes, with astrocytes being the most potent 
complement producers. Although normal synthesis in the brain is low, inflammatory 
cytokines such as IFN and TNF considerably increase complement production, especially 
of complement factor C3. Increased levels of C3 and C4 were found in the cerebrospinal 
fluid of HIV-infected patients with neurological symptoms and signs of central nervous 
system dysfunction, supporting the hypothesis of an association between complement and 
HIV-induced neurodegeneration. HIV-induced upregulation of C3 expression in astrocytes 
may be an important reason for increased complement levels in the cerebrospinal fluid of 
HIV-infected patients. HIV-1 increased the C3 levels in astrocyte culture supernatants from 
30 to up to 400 ng/ml. Signal transduction studies revealed that adenylate cyclase activation 
with upregulation of cyclic AMP is the central signalling pathway to mediate that increase. 
Furthermore, activity of protein kinase C was necessary for HIV induction of C3, since 
inhibition of protein kinase C by prolonged exposure to the phorbol ester tetradecanoyl 
phorbol acetate partly abolished the HIV effect.  
Confocal microscopy analysis of human MDMs treated with myr- and myr+ Nef–FITC 
indicated that both proteins are internalized and localize in an intracytoplasmic punctate 
pattern and at the cell margin (Alessandrini et al., 2000; Olivetta et al., 2003) as described for 
cells that endogenously express the protein (Greenberg et al., 1997). The protein lacking the 
acceptor signal for myristoylation (G2→A Nef) is internalized, but loose at least in part the 
co-localization signal with the cell membrane (Alessandrini et al., 2000). The wt protein does 
not bind MDMs at 4 °C suggesting that it does not recognize specific receptor on the cell 
membrane, but it might be internalized exploiting the endocytic/pinocytotic MDMs 
machinery. Indeed Nef was shown to perturb model membranes opening an avenue for its 
translocation through cell membranes (Gerlach et al., 2010; Szilluweit et al., 2009). 
All these experimental evidences suggest that extracellular Nef if present in vivo could 
induce specific cellular response in uninfected cells that might contribute directly and 
indirectly to the onset of AIDS. Indeed the presence of extracellular Nef in infected 
individuals has not been extensively evaluated. The viral protein has been found in the 
serum of some HIV-1 infected patients at concentration ranging from 1 to 10 ng/ml (Fujii et 
al., 1996c). This concentration might be even higher in the lymphonodal germinal centers, 
where virion-trapping dendritic cells, virion-infected CD4+ T cells and macrophages are 
densely packed (Pantaleo et al., 1991). In addition antibodies directed against this viral 
protein have been found in HIV-1 infected seronegative individuals supporting the possible 
detection of extracellular molecule (Ameisen et al., 1989). Nef can be released in culture 
supernatant of 293, Jurkat and THP-1 cells transfected with HIV-1NL4-3-, HIV-2- or SIV-Nef 
expressing vectors indicating that it can be secreted (James et al., 2004). The genetic 
characterization of Nef-induced secretion has identified that the N-terminal 70 amino acids 
were sufficient for induction of secretion of Nef- containing vescicles in several cell lines and 
identified critical aminoacid residues: (1) a basic cluster of four arginine residues (aa 17, 19, 
21, 22), (2) the phosphofurin acidic cluster sequence (PACS; Glu62–65), and (3) a previously 
uncharacterized domain spanning amino acid residues 66–70 (VGFPV), which has been 
named the secretion modification region (SMR). Interestingly, in vivo analysis performed on 
infected follicles of lymphoid tissue showed the presence of Nef positive IgD+ B cells at the 
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edge of the germinal center and in the interfollicular area even if these cells were unlikely to 
be infected by HIV-1 (Qiao et al., 2006). This observation suggested that Nef, produced 
inside the HIV infected cells via the transcription of the proviral genome, can be transferred 
in vivo to bystander non infected cells.  
4. Nef transfer from infected to uninfected cells 
The transfer of HIV viral proteins by nanotubes (Sowinski et al., 2008) and the transfer of 
Nef by vesicles (Campbell et al., 2008) has been recently documented. Interestingly in 
September 2009, Xu and collaborators (Xu et al., 2009) reported that HIV-1 infected 
macrophages form B cell–targeting conduits in response to Nef expression. These conduits 
translocate membrane-bound Nef and Nef-containing endosomes from macrophages to 
follicular B cells via a mechanism propelled by actin, mediated by Vav and dependent on 
GTPases. These results provided the evidence that infected cells can transfer the viral 
protein via cell to cell contact to uninfected cells. It appears that Nef-mediated activation of 
membrane trafficking is bidirectional, connecting endocytosis with exocytosis as occurs in 
activated T cells. Interestingly Nef expression induced an extensive secretory activity also in 
infected and, surprisingly, in non infected T cells, leading to the massive release of 
microvesicle clusters, a phenotype observed in vitro and in 36%–87% of primary CD4+ T 
cells from HIV-infected individuals. Consistent with exocytosis in noninfected cells, Nef is 
transferred to bystander cells upon cell-to-cell contact and subsequently induces secretion in 
an Erk1/2-dependent manner. Thus, Nef alters membrane dynamics mimicking those of 
activated T cells and causing a transfer of infected cell signalling to bystander cells 
(Muratori et al., 2009). Based on these findings, it was hypothesized that Nef transfer could 
potentially explain the effects observed in bystander cells in vivo. In agreement with this 
hypothesis conduits-mediated shuttling of Nef from infected macrophages to B cells 
attenuated IgG2 and IgA class switching in systemic and intestinal lymphoid follicles 
suggesting that HIV-1 exploits intercellular ‘highways’ as a ‘Trojan horse’ to deliver Nef to B 
cells and evade specific humoral immunity systemically and at mucosal sites of entry. The 
stronger virus-specific IgG2 and IgA responses observed in Long Term Non Progressor 
infected by Nef-deficient HIV-1 further supports this possibility (Xu et al., 2009). In addition 
Lenassi et al. (Lenassi et al., 2010) demonstrated that the expression of Nef not only 
augmented the production of the exosomes from T cells (Jurkat, SupT1 and primary T cells) 
but also resulted in the packaging of Nef into these vesicles which, upon contact, leads to an 
activation-induced cell death in the resting CD4+ T lymphocytes (bystander cells). It is 
known that subsets of cellular proteins are specifically targeted to exosomes reflecting the 
site of their formation. Proteomic profiling of Nef exosomes originating from Jurkat and 
SupT1 cells indicates that Nef exosomes form at the plasma membrane in Jurkat and in 
Multivescicular Bodies in SupT cells. Instead Nef exosomes from PBLs represent a mixture 
of secreted vesicles of plasma membrane and late endosomal origin. Therefore, Nef 
increases the production of exosomes from several distinct cellular compartments. Nef 
release through exosomes was conserved also during HIV-1 infection of peripheral blood 
lymphocytes (PBLs). Thus, HIV-infected cells export Nef in bioactive vesicles that might 
facilitate the depletion of CD4+ T cells in vivo.  
Figure 1 schematically summarizes Nef-induced effects and transfer in uninfected cells. 
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Fig. 1. Schematic representation of Nef-induced signalling and transfer in uninfected cells.  
A: Nef treatment of MDMs induces signal transduction events followed by production of 
inflammatory chemo/cytokines and IFN; B: infected MDMs transfer Nef via cellular 
protusions; C: exogenous Nef induces apoptosis in T cells via interaction with CXCR4; D: T 
cells expressing Nef release Nef-containing – exosomes that are transferred to bystander cells; 
E: extracellular Nef induces up regulation of specific maturation markers in immature DC. 
5. Perspectives and future directions 
In recent years, it has become apparent that many viruses induce signal transduction events 
in concert with virus entry and/or as a consequence of the intracellular expression and 
release of viral proteins. These events can trigger a variety of changes in the cell, including 
induction of apoptosis, cytoskeleton rearrangements and global reprogramming of cellular 
transcription to favour viral replication or persistence. At the same time the innate sensing 
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of some viral components by cells triggers signal transduction pathways to induce antiviral 
responses. At present, we are only beginning to decipher the mechanism and the 
consequences of these events to viral replication and pathogenesis in the host. As far as Nef 
concerns, its ability to induce exosome formation and cell to cell connection mediating its 
transfer and the transfer of signalling molecules between cells open new road to understand 
its complex role in HIV-1-host interaction and highlights the complexity of functions of 
biological molecules. How Nef is able to switch on signalling events in uninfected cells and 
the patho-physiological relevance of this phenomenon requires further investigations and 
might disclosure new therapeutic targets for treatment of seropositive patients. 
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